List of Tables

Table 1. Antibody and Recombinant Protein CDMO Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Antibody and Recombinant Protein CDMO Market Restraints

Table 3. Antibody and Recombinant Protein CDMO Market Trends

Table 4. Antibody and Recombinant Protein CDMO Industry Policy

Table 5. Global Antibody and Recombinant Protein CDMO Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Antibody and Recombinant Protein CDMO Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Antibody and Recombinant Protein CDMO Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Antibody and Recombinant Protein CDMO Mergers & Acquisitions, Expansion Plans

Table 9. Global Antibody and Recombinant Protein CDMO Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Antibody and Recombinant Protein CDMO Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 12. China Antibody and Recombinant Protein CDMO Revenue Market Share by Company, 2020-2025

Table 13. Global Key Players of Antibody and Recombinant Protein CDMO Upstream (Raw Materials)

Table 14. Global Antibody and Recombinant Protein CDMO Typical Customers

Table 15. Antibody and Recombinant Protein CDMO Typical Distributors

Table 16. by Type, Global Antibody and Recombinant Protein CDMO Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 17. by Application, Global Antibody and Recombinant Protein CDMO Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 18. By Region, Global Antibody and Recombinant Protein CDMO Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 19. By Region, Global Antibody and Recombinant Protein CDMO Consumption Value, 2020-2031, US$ Million

Table 20. By Country, Global Antibody and Recombinant Protein CDMO Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 21. By Country, Global Antibody and Recombinant Protein CDMO Consumption Value, 2020-2031, US$ Million

Table 22. By Country, Global Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2020-2031

Table 23. Batavia Biosciences Company Information, Head Office, Market Area, and Industry Position

Table 24. Batavia Biosciences Company Profile and Main Business

Table 25. Batavia Biosciences Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 26. Batavia Biosciences Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 27. Batavia Biosciences Recent Developments

Table 28. Grifols Company Information, Head Office, Market Area, and Industry Position

Table 29. Grifols Company Profile and Main Business

Table 30. Grifols Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 31. Grifols Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 32. Grifols Recent Developments

Table 33. Cerbios-Pharma SA Company Information, Head Office, Market Area, and Industry Position

Table 34. Cerbios-Pharma SA Company Profile and Main Business

Table 35. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 36. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 37. Cerbios-Pharma SA Recent Developments

Table 38. HALIX Company Information, Head Office, Market Area, and Industry Position

Table 39. HALIX Company Profile and Main Business

Table 40. HALIX Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 41. HALIX Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 42. HALIX Recent Developments

Table 43. Biovian Oy Company Information, Head Office, Market Area, and Industry Position

Table 44. Biovian Oy Company Profile and Main Business

Table 45. Biovian Oy Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 46. Biovian Oy Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 47. Biovian Oy Recent Developments

Table 48. Catalent Company Information, Head Office, Market Area, and Industry Position

Table 49. Catalent Company Profile and Main Business

Table 50. Catalent Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 51. Catalent Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 52. Catalent Recent Developments

Table 53. Goodwin Biotechnology Company Information, Head Office, Market Area, and Industry Position

Table 54. Goodwin Biotechnology Company Profile and Main Business

Table 55. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 56. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 57. Goodwin Biotechnology Recent Developments

Table 58. Merck Company Information, Head Office, Market Area, and Industry Position

Table 59. Merck Company Profile and Main Business

Table 60. Merck Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 61. Merck Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 62. Merck Recent Developments

Table 63. Hangzhou Hs-biopharm Company Information, Head Office, Market Area, and Industry Position

Table 64. Hangzhou Hs-biopharm Company Profile and Main Business

Table 65. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 66. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 67. Hangzhou Hs-biopharm Recent Developments

Table 68. Wuxibiologics Company Information, Head Office, Market Area, and Industry Position

Table 69. Wuxibiologics Company Profile and Main Business

Table 70. Wuxibiologics Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 71. Wuxibiologics Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 72. Wuxibiologics Recent Developments

Table 73. Bioinnobio Company Information, Head Office, Market Area, and Industry Position

Table 74. Bioinnobio Company Profile and Main Business

Table 75. Bioinnobio Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 76. Bioinnobio Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 77. Bioinnobio Recent Developments

Table 78. Thousand Oaks Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 79. Thousand Oaks Biopharmaceuticals Company Profile and Main Business

Table 80. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 81. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 82. Thousand Oaks Biopharmaceuticals Recent Developments

Table 83. Eurogentec Company Information, Head Office, Market Area, and Industry Position

Table 84. Eurogentec Company Profile and Main Business

Table 85. Eurogentec Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 86. Eurogentec Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 87. Eurogentec Recent Developments

Table 88. HJB Company Information, Head Office, Market Area, and Industry Position

Table 89. HJB Company Profile and Main Business

Table 90. HJB Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 91. HJB Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 92. HJB Recent Developments

Table 93. Bibo Pharma Company Information, Head Office, Market Area, and Industry Position

Table 94. Bibo Pharma Company Profile and Main Business

Table 95. Bibo Pharma Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 96. Bibo Pharma Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 97. Bibo Pharma Recent Developments

Table 98. MabPlex International Company Information, Head Office, Market Area, and Industry Position

Table 99. MabPlex International Company Profile and Main Business

Table 100. MabPlex International Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 101. MabPlex International Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 102. MabPlex International Recent Developments

Table 103. Genscriptprobio Company Information, Head Office, Market Area, and Industry Position

Table 104. Genscriptprobio Company Profile and Main Business

Table 105. Genscriptprobio Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 106. Genscriptprobio Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 107. Genscriptprobio Recent Developments

Table 108. Vetter Company Information, Head Office, Market Area, and Industry Position

Table 109. Vetter Company Profile and Main Business

Table 110. Vetter Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 111. Vetter Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 112. Vetter Recent Developments

Table 113. Etinpro (Beijing) Co Company Information, Head Office, Market Area, and Industry Position

Table 114. Etinpro (Beijing) Co Company Profile and Main Business

Table 115. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 116. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 117. Etinpro (Beijing) Co Recent Developments

Table 118. Boehringer Ingelheim BioXcellence Company Information, Head Office, Market Area, and Industry Position

Table 119. Boehringer Ingelheim BioXcellence Company Profile and Main Business

Table 120. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 121. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 122. Boehringer Ingelheim BioXcellence Recent Developments

Table 123. Lonza Company Information, Head Office, Market Area, and Industry Position

Table 124. Lonza Company Profile and Main Business

Table 125. Lonza Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 126. Lonza Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 127. Lonza Recent Developments

Table 128. 3SBio Inc Company Information, Head Office, Market Area, and Industry Position

Table 129. 3SBio Inc Company Profile and Main Business

Table 130. 3SBio Inc Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 131. 3SBio Inc Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 132. 3SBio Inc Recent Developments

Table 133. Porton Company Information, Head Office, Market Area, and Industry Position

Table 134. Porton Company Profile and Main Business

Table 135. Porton Antibody and Recombinant Protein CDMO Models, Specifications, and Application

Table 136. Porton Antibody and Recombinant Protein CDMO Revenue and Gross Margin, US$ Million, 2020-2025

Table 137. Porton Recent Developments

List of Figures

Figure 1. Antibody and Recombinant Protein CDMO Picture

Figure 2. Global Antibody and Recombinant Protein CDMO Consumption Value, (US$ million) & (2020-2031)

Figure 3. China Antibody and Recombinant Protein CDMO Consumption Value, (US$ million) & (2020-2031)

Figure 4. By Consumption Value, China Antibody and Recombinant Protein CDMO Market Share of Global, 2020-2031

Figure 5. Global Antibody and Recombinant Protein CDMO Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 6. China Antibody and Recombinant Protein CDMO Key Participants, Market Share, 2024

Figure 7. Antibody and Recombinant Protein CDMO Industry Chain

Figure 8. Antibody and Recombinant Protein CDMO Procurement Model

Figure 9. Antibody and Recombinant Protein CDMO Sales Model

Figure 10. Antibody and Recombinant Protein CDMO Sales Channels, Direct Sales, and Distribution

Figure 11. Antibody CDMO

Figure 12. Recombinant Protein CDMO

Figure 13. by Type, Global Antibody and Recombinant Protein CDMO Consumption Value, 2020-2031, US$ Million

Figure 14. by Type, Global Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2020-2031

Figure 15. Pharmaceutical Company

Figure 16. Biotechnology Company

Figure 17. Generic Company

Figure 18. by Application, Global Antibody and Recombinant Protein CDMO Consumption Value, 2020-2031, US$ Million

Figure 19. by Application, Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2020-2031

Figure 20. By Region, Global Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2020-2031

Figure 21. North America Antibody and Recombinant Protein CDMO Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 22. By Country, North America Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024

Figure 23. Europe Antibody and Recombinant Protein CDMO Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 24. By Country, Europe Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024

Figure 25. Asia Pacific Antibody and Recombinant Protein CDMO Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 26. By Country/Region, Asia Pacific Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024

Figure 27. South America Antibody and Recombinant Protein CDMO Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 28. By Country, South America Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024

Figure 29. Middle East & Africa Antibody and Recombinant Protein CDMO Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 30. United States Antibody and Recombinant Protein CDMO Consumption Value, 2020-2031, US$ Million

Figure 31. by Type, United States Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 32. by Application, United States Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 33. Europe Antibody and Recombinant Protein CDMO Consumption Value, 2020-2031, US$ Million

Figure 34. by Type, Europe Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 35. by Application, Europe Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 36. China Antibody and Recombinant Protein CDMO Consumption Value, 2020-2031, US$ Million

Figure 37. by Type, China Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 38. by Application, China Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 39. Japan Antibody and Recombinant Protein CDMO Consumption Value, 2020-2031, US$ Million

Figure 40. by Type, Japan Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 41. by Application, Japan Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 42. South Korea Antibody and Recombinant Protein CDMO Consumption Value, 2020-2031, US$ Million

Figure 43. by Type, South Korea Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 44. by Application, South Korea Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 45. Southeast Asia Antibody and Recombinant Protein CDMO Consumption Value, 2020-2031, US$ Million

Figure 46. by Type, Southeast Asia Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 47. by Application, Southeast Asia Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 48. India Antibody and Recombinant Protein CDMO Consumption Value, 2020-2031, US$ Million

Figure 49. by Type, India Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 50. by Application, India Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 51. Middle East & Africa Antibody and Recombinant Protein CDMO Consumption Value, 2020-2031, US$ Million

Figure 52. by Type, Middle East & Africa Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 53. by Application, Middle East & Africa Antibody and Recombinant Protein CDMO Consumption Value Market Share, 2024 VS 2031

Figure 54. Research Methodology

Figure 55. Breakdown of Primary Interviews

Figure 56. Bottom-up Approaches

Figure 57. Top-down Approaches